Fig. 2From: Identification of compound heterozygous variants in MSH4 as a novel genetic cause of diminished ovarian reserveMinigene Analysis indicates MSH4 c.2222_2225delAAGA does not change splicing. (A, E) Schematic illustration of minigene construction. To construct the pcDNA3.1-MSH4-wt/mut minigene, exon 15 (201Â bp), a portion of intron 15 (469Â bp), exon 16 (119Â bp), intron 16 (1326Â bp), and exon 17 (129Â bp) of the MSH4 gene were cloned into the pcDNA3.1 vector. To construct the pcMINI-MSH4-wt/mut minigene, a portion of intron 15 (425Â bp), exon 16 (119Â bp) and a portion of intron 16 (576Â bp) of MSH4 gene was cloned into the pcMINI vector. (B, F) Sanger sequencing results of the minigene constructs. (C, G) RT-PCR products of the minigenes expressed in HeLa and 293T cells. (D, H) Sanger sequencing of the amplified products revealed no significant difference in splicing between the wild-type and mutant minigenesBack to article page